LB Pharmaceuticals Inc.
LB Pharmaceuticals develops neuromedicines for brain disorders.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story
November 2026
September 2026
August 2026
July 2026
LB Pharmaceuticals develops neuromedicines for brain disorders.
November 2026
September 2026
August 2026
July 2026